Heart Failure Clinical Trial
Attain StarFixâ„¢ Model 4195 Left Ventricular Lead
Summary
People who have abnormal heart beats, or whose heart does not beat on its own, may need an electronic device called a pacemaker or a defibrillator. Furthermore, people whose hearts have a reduced pumping ability may need a device are called cardiac resynchronization therapy (CRT) device. A CRT device is implanted surgically just under the skin in the upper chest area. This device then helps the heart beat at a regular rhythm by sending electrical signals (pacing) directly to the heart tissue through flexible wires called leads. The device may also be able to stop the heart from beating too fast. Three leads are implanted into the chambers of your heart. Two of the leads will be placed on the right side of your heart. The third lead is placed on the left side of your heart and is the lead being studied.
The purpose of this study is to evaluate the safety and efficacy of the Attain StarFixTM Model 4195 Left Ventricular (LV) Lead. This particular model lead has special characteristics that may help to better keep it in position once it is implanted into the left ventricle. It is also "steroid-eluting" which means that over time it slowly releases a small amount of medication into the heart tissue to help prevent too much swelling around the area it is implanted.
Eligibility Criteria
Inclusion Criteria:
QRS > 130 ms (The QRS interval is a measurement of how the electrical signal involved in a heart beat travels, or is conducted, through the ventricles. A wide QRS (more than 120) suggests that there is a conduction problem, or block, in the ventricles.)
Left Ventricular Ejection Fraction (EF) < 35% (Ejection Fraction is a measurement of how well the left ventricle pumps blood out to the rest of the body. The higher the EF the more blood the ventricle is pumping.)
Subject has moderate to severe heart failure despite medications
Exclusion Criteria:
Subjects with a previous lead in the left ventricle or previous implant attempt within 30 days of implant or ongoing complications from a previous unsuccessful attempt
Subjects with chest pain or who have had a heart attack within the past month before enrollment in the study
Subjects that have had certain surgeries on their heart within the past three months
Subjects with chronic (permanent) fast heart beats in the upper chambers of the heart (atrial arrhythmias)
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Long Beach California, , United States
Palo Alto California, , United States
Newark Delaware, , United States
Jacksonville Florida, , United States
Orlando Florida, , United States
Atlanta Georgia, , United States
Lexington Kentucky, , United States
Grand Rapids Michigan, , United States
Saginaw Michigan, , United States
St. Paul Minnesota, , United States
St. Louis Missouri, , United States
Lincoln Nebraska, , United States
Newark New Jersey, , United States
Rochester New York, , United States
Durham North Carolina, , United States
Germantown Tennessee, , United States
Nashville Tennessee, , United States
Dallas Texas, , United States
Temple Texas, , United States
Milwaukee Wisconsin, , United States
Calgary Alberta, , Canada
Victoria British Columbia, , Canada
London Ontario, , Canada
Sainte-Foy Quebec, , Canada
Milano , , Italy
How clear is this clinincal trial information?